First Time Loading...
W

Walvax Biotechnology Co Ltd
SZSE:300142

Watchlist Manager
Walvax Biotechnology Co Ltd
SZSE:300142
Watchlist
Price: 15.12 CNY 0.2% Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Walvax Biotechnology Co Ltd

Wall Street analysts forecast Walvax Biotechnology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Walvax Biotechnology Co Ltd is 20.4 CNY with a low forecast of 15.15 CNY and a high forecast of 26.25 CNY.

Lowest Forecast
Wall Street Target
15.15 CNY
0% Upside
Average Forecast
Wall Street Target
20.4 CNY
35% Upside
Highest Forecast
Wall Street Target
26.25 CNY
74% Upside
Lowest
Price Target
15.15 CNY
0% Upside
Average
Price Target
20.4 CNY
35% Upside
Highest
Price Target
26.25 CNY
74% Upside
Walvax Biotechnology Co Ltd Competitors:
Price Targets
PRLD
Prelude Therapeutics Inc
60% Upside
MGNX
MacroGenics Inc
77% Upside
TLX
Telix Pharmaceuticals Ltd
4% Upside
S
096530
Seegene Inc
69% Upside
PRLD
Prelude Therapeutics Inc
60% Upside
MGNX
MacroGenics Inc
77% Upside
TLX
Telix Pharmaceuticals Ltd
4% Upside
S
096530
Seegene Inc
69% Upside
A
ALVO
Alvotech SA
21% Upside
HOOK
HOOKIPA Pharma Inc
434% Upside
RCUS
Arcus Biosciences Inc
152% Upside
EXEL
Exelixis Inc
25% Upside

Revenue
Forecast

Revenue Estimate
Walvax Biotechnology Co Ltd

For the last 8 years the compound annual growth rate for Walvax Biotechnology Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 14%.

19%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Walvax Biotechnology Co Ltd

The compound annual growth rate of Walvax Biotechnology Co Ltd's operating income for the next 3 years is 36%.

N/A
Past Growth
36%
Estimated Growth
Estimates Accuracy
-32%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Walvax Biotechnology Co Ltd

The compound annual growth rate of Walvax Biotechnology Co Ltd's net income for the next 3 years is 46%.

N/A
Past Growth
46%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Walvax Biotechnology Co Ltd's stock price target?
Price Target
20.4 CNY

According to Wall Street analysts, the average 1-year price target for Walvax Biotechnology Co Ltd is 20.4 CNY with a low forecast of 15.15 CNY and a high forecast of 26.25 CNY.

What is Walvax Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Walvax Biotechnology Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 14%.

What is Walvax Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
36%

The compound annual growth rate of Walvax Biotechnology Co Ltd's operating income for the next 3 years is 36%.

What is Walvax Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
46%

The compound annual growth rate of Walvax Biotechnology Co Ltd's net income for the next 3 years is 46%.

ALPHA SPREAD
Join more than 135,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.